China Universal Asset Management Co., Ltd. Cabaletta Bio, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.23 Billion
- Q4 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,686 shares of CABA stock, worth $36,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,686Holding current value
$36,234% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding CABA
# of Institutions
89Shares Held
73.5MCall Options Held
1.1MPut Options Held
14.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$22.4 Million7.24% of portfolio
-
Jennison Associates LLC8.91MShares$20.6 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$20.4 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.36MShares$19.3 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$11.6 Million1.86% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $67M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...